{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:30:07Z","timestamp":1787063407000,"version":"build-2736575974"},"reference-count":92,"publisher":"Harborside Press, LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.<\/jats:p>","DOI":"10.6004\/jnccn.2022.0057","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T16:05:46Z","timestamp":1668009946000},"page":"1267-1275","source":"Crossref","is-referenced-by-count":19,"title":["Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology"],"prefix":"10.6004","volume":"20","author":[{"given":"Matthew","family":"Barth","sequence":"first","affiliation":[{"name":"1Roswell Park Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Xavier","sequence":"additional","affiliation":[{"name":"2Children\u2019s of Alabama\/O\u2019Neal Comprehensive Cancer Center at UAB;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saro","family":"Armenian","sequence":"additional","affiliation":[{"name":"3City of Hope National Medical Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony N.","family":"Audino","sequence":"additional","affiliation":[{"name":"4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Blazin","sequence":"additional","affiliation":[{"name":"5Indiana University Melvin and Bren Simon Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bloom","sequence":"additional","affiliation":[{"name":"6University of Michigan Rogel Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong","family":"Chung","sequence":"additional","affiliation":[{"name":"7UC Davis Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Davies","sequence":"additional","affiliation":[{"name":"8Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilda","family":"Ding","sequence":"additional","affiliation":[{"name":"9UCSD Rady Children\u2019s Hospital\/UC San Diego Moores Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Ford","sequence":"additional","affiliation":[{"name":"10Fred & Pamela Buffett Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Galardy","sequence":"additional","affiliation":[{"name":"11Mayo Clinic Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabi","family":"Hanna","sequence":"additional","affiliation":[{"name":"12Case Comprehensive Cancer Center\/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hayashi","sequence":"additional","affiliation":[{"name":"13Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Lee-Miller","sequence":"additional","affiliation":[{"name":"14University of Wisconsin Carbone Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Judit","family":"Machnitz","sequence":"additional","affiliation":[{"name":"15The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly W.","family":"Maloney","sequence":"additional","affiliation":[{"name":"16Children\u2019s Hospital of Colorado\/University of Colorado Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianna","family":"Marks","sequence":"additional","affiliation":[{"name":"17Stanford Cancer Institute;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Martin","sequence":"additional","affiliation":[{"name":"18Duke Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"McCall","sequence":"additional","affiliation":[{"name":"19The University of Texas MD Anderson Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Pacheco","sequence":"additional","affiliation":[{"name":"20UT Southwestern Simmons Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne F.","family":"Reilly","sequence":"additional","affiliation":[{"name":"21Abramson Cancer Center at the University of Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Roshal","sequence":"additional","affiliation":[{"name":"22Memorial Sloan Kettering Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Song","sequence":"additional","affiliation":[{"name":"23UCLA Jonsson Comprehensive Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Weinstein","sequence":"additional","affiliation":[{"name":"24Robert H. Lurie Comprehensive Cancer Center of Northwestern University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Zarnegar-Lumley","sequence":"additional","affiliation":[{"name":"25Vanderbilt-Ingram Cancer Center; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"McMillian","sequence":"additional","affiliation":[{"name":"26National Comprehensive Cancer Network."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Schonfeld","sequence":"additional","affiliation":[{"name":"26National Comprehensive Cancer Network."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"Sundar","sequence":"additional","affiliation":[{"name":"26National Comprehensive Cancer Network."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"ref501","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2008.07393.x","article-title":"Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science","volume":"144","author":"Hochberg","year":"2009","journal-title":"Br J Haematol"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/pbc.21821","article-title":"Primary mediastinal B-cell lymphoma in the pediatric patient: can a rational approach to therapy be based on adult studies?","volume":"52","author":"Attias","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma","volume":"123","author":"Twa","year":"2014","journal-title":"Blood"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1200\/JCO.19.01492","article-title":"Nivolumab combined with brentuximab vedotin for relapsed\/refractory primary mediastinal large B-cell lymphoma: efficacy and safety from the phase II CheckMate 436 study","volume":"37","author":"Zinzani","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH- rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med"},{"key":"ref831","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.bbmt.2018.06.009","article-title":"Outcomes of relapsed and refractory primary mediastinal (thymic) large B cell lymphoma treated with second-line therapy and intent to transplant","volume":"24","author":"Vardhana","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1182\/blood-2017-01-764258","article-title":"Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial","volume":"129","author":"Zinzani","year":"2017","journal-title":"Blood"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3324\/haematol.2021.278971","article-title":"Dose-adjusted EPOCH- rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma","volume":"106","author":"Kn\u00f6rr","year":"2021","journal-title":"Haematologica"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood-2005-11-4742","article-title":"Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival","volume":"108","author":"Roberts","year":"2006","journal-title":"Blood"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41409-017-0063-7","article-title":"Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation","volume":"53","author":"Avivi","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1470-2045(20)30023-1","article-title":"Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial","volume":"21","author":"Davis","year":"2020","journal-title":"Lancet Oncol"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1200\/JCO.21.00920","article-title":"Dose-adjusted etoposide, doxorubicin, and cyclophosphamide with vincristine and prednisone plus rituximab therapy in children and adolescents with primary mediastinal B-Cell lymphoma: a multicenter phase II trial","volume":"39","author":"Burke","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1200\/JCO.19.01389","article-title":"Pembrolizumab in relapsed or refractory primary mediastinal large B-Cell lymphoma","volume":"37","author":"Armand","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","article-title":"The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence","volume":"131","author":"Burkhardt","year":"2005","journal-title":"Br J Haematol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jasc.2020.04.004","article-title":"An update on touch preparations of small biopsies","volume":"9","author":"Satturwar","year":"2020","journal-title":"J Am Soc Cytopathol"},{"key":"ref531","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/sj.leu.2404919","article-title":"Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH)","volume":"21","author":"Wessendorf","year":"2007","journal-title":"Leukemia"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1200\/JCO.2003.08.151","article-title":"Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-M\u00fcnster Group","volume":"21","author":"Seidemann","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref731","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood-2012-04-422709","article-title":"Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB\/LMB96 mature B-NHL therapy","volume":"121","author":"Gerrard","year":"2013","journal-title":"Blood"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00259-009-1276-9","article-title":"Role of PET\/CT in malignant pediatric lymphoma","volume":"37","author":"Riad","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00259-009-1276-9","article-title":"Role of PET\/CT in malignant pediatric lymphoma","volume":"37","author":"Riad","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1098-2264(2001)9999:9999<::AID-GCC1105>3.0.CO;2-I","article-title":"Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line","volume":"30","author":"Bentz","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood-2005-11-4742","article-title":"Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival","volume":"108","author":"Roberts","year":"2006","journal-title":"Blood"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.celrep.2015.10.008","article-title":"Genomic alterations in CIITA are frequent in primary mediastinal large B cell lymphoma and are associated with diminished MHC class II expression","volume":"13","author":"Mottok","year":"2015","journal-title":"Cell Rep"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","article-title":"The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence","volume":"131","author":"Burkhardt","year":"2005","journal-title":"Br J Haematol"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/pbc.21821","article-title":"Primary mediastinal B-cell lymphoma in the pediatric patient: can a rational approach to therapy be based on adult studies?","volume":"52","author":"Attias","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41409-017-0063-7","article-title":"Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation","volume":"53","author":"Avivi","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1200\/JCO.2004.02.104","article-title":"Utility of fine-needle aspiration as a diagnostic technique in lymphoma","volume":"22","author":"Hehn","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref891","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1470-2045(20)30023-1","article-title":"Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial","volume":"21","author":"Davis","year":"2020","journal-title":"Lancet Oncol"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ajh.26301","article-title":"Efficacy and safety of CD19- directed CAR-T cell therapies in patients with relapsed\/refractory aggressive B-cell lymphomas: observations from the JULIET, ZUMA-1, and TRANSCEND trials","volume":"96","author":"Westin","year":"2021","journal-title":"Am J Hematol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-199607000-00012","article-title":"Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (\u201cGroupe d\u2019Etude des Lymphomes de l\u2019Adulte\u201d) study","volume":"20","author":"Cazals-Hatem","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2010.030809","article-title":"Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children","volume":"96","author":"Oschlies","year":"2011","journal-title":"Haematologica"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood-2016-12-758383","article-title":"Safety and tolerability of pembrolizumab in patients with relapsed\/refractory primary mediastinal large B-cell lymphoma","volume":"130","author":"Zinzani","year":"2017","journal-title":"Blood"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1158\/2159-8290.CD-21-1094","article-title":"A summary of the inaugural WHO Classification of Pediatric Tumors: transitioning from the optical into the molecular era","volume":"12","author":"Pfister","year":"2022","journal-title":"Cancer Discov"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH- rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood-2012-04-422709","article-title":"Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB\/LMB96 mature B-NHL therapy","volume":"121","author":"Gerrard","year":"2013","journal-title":"Blood"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/08880018.2013.834400","article-title":"Pediatric Burkitt\u2019s lymphoma and diffuse B-cell lymphoma: are surveillance scans required?","volume":"31","author":"Eissa","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/sj.leu.2404324","article-title":"Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma","volume":"20","author":"Weniger","year":"2006","journal-title":"Leukemia"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2010.030809","article-title":"Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children","volume":"96","author":"Oschlies","year":"2011","journal-title":"Haematologica"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1111\/bjh.16761","article-title":"Primary mediastinal large B-cell lymphoma in paediatric and adolescent patients: emerging questions in the era of immunotherapy","volume":"190","author":"Kohorst","year":"2020","journal-title":"Br J Haematol"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/bjh.16461","article-title":"Treatment of relapsed\/refractory paediatric aggressive B-cell non-Hodgkin lymphoma","volume":"189","author":"Moleti","year":"2020","journal-title":"Br J Haematol"},{"key":"ref811","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/08880018.2013.834400","article-title":"Pediatric Burkitt\u2019s lymphoma and diffuse B-cell lymphoma: are surveillance scans required?","volume":"31","author":"Eissa","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma","volume":"123","author":"Twa","year":"2014","journal-title":"Blood"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1182\/blood-2017-01-764258","article-title":"Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial","volume":"129","author":"Zinzani","year":"2017","journal-title":"Blood"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/sj.leu.2404919","article-title":"Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH)","volume":"21","author":"Wessendorf","year":"2007","journal-title":"Leukemia"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1182\/blood.2019004296","article-title":"Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach","volume":"136","author":"Hayden","year":"2020","journal-title":"Blood"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1200\/JCO.2003.08.151","article-title":"Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-M\u00fcnster Group","volume":"21","author":"Seidemann","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1200\/JCO.19.01389","article-title":"Pembrolizumab in relapsed or refractory primary mediastinal large B-Cell lymphoma","volume":"37","author":"Armand","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1158\/2159-8290.CD-21-1094","article-title":"A summary of the inaugural WHO Classification of Pediatric Tumors: transitioning from the optical into the molecular era","volume":"12","author":"Pfister","year":"2022","journal-title":"Cancer Discov"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1098-2264(2001)9999:9999<::AID-GCC1105>3.0.CO;2-I","article-title":"Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line","volume":"30","author":"Bentz","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/bjh.14951","article-title":"Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose- adjusted EPOCH-R","volume":"179","author":"Giulino-Roth","year":"2017","journal-title":"Br J Haematol"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/bjh.16461","article-title":"Treatment of relapsed\/refractory paediatric aggressive B-cell non-Hodgkin lymphoma","volume":"189","author":"Moleti","year":"2020","journal-title":"Br J Haematol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2008.07393.x","article-title":"Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science","volume":"144","author":"Hochberg","year":"2009","journal-title":"Br J Haematol"},{"key":"ref61","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1200\/JCO.19.01492","article-title":"Nivolumab combined with brentuximab vedotin for relapsed\/refractory primary mediastinal large B-cell lymphoma: efficacy and safety from the phase II CheckMate 436 study","volume":"37","author":"Zinzani","year":"2019","journal-title":"J Clin Oncol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1200\/JCO.2004.02.104","article-title":"Utility of fine-needle aspiration as a diagnostic technique in lymphoma","volume":"22","author":"Hehn","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1080\/10428190310001623810","article-title":"Pathobiology of primary mediastinal B-cell lymphoma","volume":"44","author":"Pileri","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/asheducation-2016.1.589","article-title":"Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum","volume":"2016","author":"Sandlund","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1080\/10428190310001623810","article-title":"Pathobiology of primary mediastinal B-cell lymphoma","volume":"44","author":"Pileri","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/gcc.20420","article-title":"Gains of REL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein","volume":"46","author":"Weniger","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.bbmt.2018.06.009","article-title":"Outcomes of relapsed and refractory primary mediastinal (thymic) large B cell lymphoma treated with second-line therapy and intent to transplant","volume":"24","author":"Vardhana","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/gcc.20420","article-title":"Gains of REL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein","volume":"46","author":"Weniger","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jasc.2020.04.004","article-title":"An update on touch preparations of small biopsies","volume":"9","author":"Satturwar","year":"2020","journal-title":"J Am Soc Cytopathol"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1182\/blood-2018-04-791566","article-title":"How I treat primary mediastinal B-cell lymphoma","volume":"132","author":"Giulino-Roth","year":"2018","journal-title":"Blood"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1182\/blood.2019004296","article-title":"Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach","volume":"136","author":"Hayden","year":"2020","journal-title":"Blood"},{"key":"ref451","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211048959","article-title":"Current and emerging treatment options in primary mediastinal B-cell lymphoma","volume":"12","author":"Fakhri","year":"2021","journal-title":"Ther Adv Hematol"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-199607000-00012","article-title":"Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (\u201cGroupe d\u2019Etude des Lymphomes de l\u2019Adulte\u201d) study","volume":"20","author":"Cazals-Hatem","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571","article-title":"Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene","volume":"87","author":"Joos","year":"1996","journal-title":"Blood"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"ref921","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211048959","article-title":"Current and emerging treatment options in primary mediastinal B-cell lymphoma","volume":"12","author":"Fakhri","year":"2021","journal-title":"Ther Adv Hematol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"ref931","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1111\/bjh.16761","article-title":"Primary mediastinal large B-cell lymphoma in paediatric and adolescent patients: emerging questions in the era of immunotherapy","volume":"190","author":"Kohorst","year":"2020","journal-title":"Br J Haematol"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/sj.leu.2404324","article-title":"Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma","volume":"20","author":"Weniger","year":"2006","journal-title":"Leukemia"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1182\/blood-2018-04-791566","article-title":"How I treat primary mediastinal B-cell lymphoma","volume":"132","author":"Giulino-Roth","year":"2018","journal-title":"Blood"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1200\/JCO.21.00920","article-title":"Dose-adjusted etoposide, doxorubicin, and cyclophosphamide with vincristine and prednisone plus rituximab therapy in children and adolescents with primary mediastinal B-Cell lymphoma: a multicenter phase II trial","volume":"39","author":"Burke","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref271","article-title":"Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study","author":"Dourthe","journal-title":"Haematologica"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.celrep.2015.10.008","article-title":"Genomic alterations in CIITA are frequent in primary mediastinal large B cell lymphoma and are associated with diminished MHC class II expression","volume":"13","author":"Mottok","year":"2015","journal-title":"Cell Rep"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3324\/haematol.2021.278971","article-title":"Dose-adjusted EPOCH- rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma","volume":"106","author":"Kn\u00f6rr","year":"2021","journal-title":"Haematologica"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/asheducation-2016.1.589","article-title":"Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum","volume":"2016","author":"Sandlund","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref741","article-title":"Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study","author":"Dourthe","journal-title":"Haematologica"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ajh.26301","article-title":"Efficacy and safety of CD19- directed CAR-T cell therapies in patients with relapsed\/refractory aggressive B-cell lymphomas: observations from the JULIET, ZUMA-1, and TRANSCEND trials","volume":"96","author":"Westin","year":"2021","journal-title":"Am J Hematol"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571","article-title":"Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene","volume":"87","author":"Joos","year":"1996","journal-title":"Blood"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood-2016-12-758383","article-title":"Safety and tolerability of pembrolizumab in patients with relapsed\/refractory primary mediastinal large B-cell lymphoma","volume":"130","author":"Zinzani","year":"2017","journal-title":"Blood"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/bjh.14951","article-title":"Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose- adjusted EPOCH-R","volume":"179","author":"Giulino-Roth","year":"2017","journal-title":"Br J Haematol"}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/20\/11\/article-p1267.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/20\/11\/article-p1267.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T13:22:57Z","timestamp":1668172977000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/20\/11\/article-p1267.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":92,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2022.0057","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}